(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.



Fig. 3. KCl-elicited [Ca2+]c rises through voltage-operated calcium channels. After application of 60 mM KCl for 12 seconds ({blacktriangleup}), the KCl solution was reapplied under the presence of L-type Ca2+ channel (10 µM nifedipine, A), N-type Ca2+ channel (1 µM {omega}-conotoxin GVIA, B), and P/Q-type Ca2+ channel (1 µM {omega}-agatoxin IVA, C) antagonists, a cocktail of the above three antagonists (D), or 100 µM CdCl2 (E). (F) Summary of the inhibitions of the KCl-elicited [Ca2+]c rises by VOCC antagonists; nifedipine (36.0±3.0% of control, n=10), {omega}-conotoxin GVIA (69.5±8.8%, n=5), {omega}-agatoxin IVA (92.3±6.6%, n=4), cocktail of the above three antagonists (23.2±4.1%, n=3), and CdCl2 (15.0±2.7%, n=4). *Significant difference (paired student t-test, P<0.05). Nif, nifedipine; {omega}-cono GVIA, {omega}-conotoxin GVIA; {omega}-aga IVA, {omega}-agatoxin IVA.